GlassScriptPhysician profile
Mark W Couture
NPI 1710981220
$7,695.24
in general payments reported to CMS, 2019-2025
13 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $653 · 2021: $1,585 · 2022: $1,484 · 2023: $1,826 · 2024: $797 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,265.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,035.64 | 2019-2025 | Stravix, Grafix, Grafix Xc |
| Abbott Laboratories | $1,489.10 | 2019-2022 | |
| Biotissue Holdings INC. | $850.38 | 2021-2024 | |
| Omeza LLC | $727.55 | 2023 | |
| Bioventus LLC | $553.52 | 2022-2023 | Stimrouter Implantable Kit |
| Cvrx, INC. | $492.72 | 2025 | Barostim Neo System |
| Imbed Biosciences INC. | $177.21 | 2023 | |
| Spr Therapeutics, INC | $143.59 | 2024 | Sprint Pns System |
| Kerecis Limited | $107.98 | 2020-2022 | |
| Osiris Therapeutics INC. | $61.47 | 2019 | |
| Treace Medical Concepts, INC. | $23.06 | 2022 | |
| Next Science LLC | $16.93 | 2021 | |
| Arthrosurface Incorporated | $16.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Couture listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.